The global Dry Eye Syndrome Treatment market size is predicted to grow from US$ 5998 million in 2025 to US$ 7887 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment. In this report, we mainly study the drugs and eye drops for dry eye.

The Dry Eye Syndrome market is driven by the rising prevalence of dry eye conditions globally, fueled by aging populations, increased screen time, and lifestyle-related factors. The widespread use of digital devices has significantly contributed to eye strain and reduced blink rates, leading to a surge in dry eye cases, especially among younger demographics. Additionally, growing awareness of ocular health and improved diagnosis through advanced diagnostic tools have increased patient identification and treatment rates. The introduction of innovative therapies, including anti-inflammatory eye drops, tear-stimulating drugs, and device-based treatments, is also expanding the market landscape.

Despite growing demand, the Dry Eye Syndrome market faces several challenges, including underdiagnosis, variable symptoms, and limited long-term treatment efficacy. Many patients remain undiagnosed due to the overlap of symptoms with other ocular conditions and the subjective nature of the disease. Current treatments often offer only temporary relief rather than a cure, leading to poor adherence and patient dissatisfaction. Moreover, the development of new therapies is hindered by the complex pathophysiology of the condition, which involves both aqueous and evaporative components. Addressing these challenges requires improved diagnostic criteria, personalized treatment approaches, and increased investment in research and clinical trials.

Infinity Market Research newest research report, the Dry Eye Syndrome Treatment Industry Forecast looks at past sales and reviews total world Dry Eye Syndrome Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Dry Eye Syndrome Treatment sales for 2025 through 2031. With Dry Eye Syndrome Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Eye Syndrome Treatment industry.

This Insight Report provides a comprehensive analysis of the global Dry Eye Syndrome Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Eye Syndrome Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Dry Eye Syndrome Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Eye Syndrome Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Eye Syndrome Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Dry Eye Syndrome Treatment market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Liquid Drops
    Gel
    Liquid Wipes
    Eye Ointment
    Other

Segmentation by Application:

    Hospital
    Clinic
    Home Care

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    AbbVie
    Alcon
    Novartis
    Santen Pharma
    Johnson & Johnson
    Bausch & Lomb
    Thea pharmaceuticals
    URSAPHARM
    SIMILASAN
    Akorn
    United Laboratories
    Sun Pharmaceutical
    Jianfeng Group
    OmniVision Pharma
    Rohto
    Prestige Consumer Healthcare
    LION
    Kenvue (VISINE)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Dry Eye Syndrome Treatment market?
What factors are driving Dry Eye Syndrome Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dry Eye Syndrome Treatment market opportunities vary by end market size?
How does Dry Eye Syndrome Treatment break out by Type, by Application?